Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $94.75 Average Price Target from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $94.75.

Several brokerages have issued reports on ACHC. TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 5th. TD Cowen increased their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. Royal Bank of Canada restated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, Barclays started coverage on Acadia Healthcare in a report on Wednesday, March 6th. They set an “overweight” rating and a $100.00 target price for the company.

Acadia Healthcare Stock Up 0.7 %

Shares of NASDAQ ACHC opened at $70.74 on Friday. The firm has a market capitalization of $6.54 billion, a price-to-earnings ratio of -282.95, a PEG ratio of 2.07 and a beta of 1.31. The business has a 50-day moving average of $78.68 and a 200-day moving average of $77.72. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 12 month low of $66.49 and a 12 month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million during the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. Acadia Healthcare’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.70 earnings per share. Sell-side analysts expect that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.80% of the company’s stock.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently modified their holdings of ACHC. Avidity Partners Management LP boosted its position in shares of Acadia Healthcare by 61.8% during the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after buying an additional 441,692 shares during the last quarter. Sea Cliff Partners Management LP purchased a new stake in shares of Acadia Healthcare during the fourth quarter valued at $26,338,000. Vaughan Nelson Investment Management L.P. purchased a new stake in shares of Acadia Healthcare during the fourth quarter valued at $24,157,000. OFI Invest Asset Management boosted its position in Acadia Healthcare by 290.5% in the third quarter. OFI Invest Asset Management now owns 331,129 shares of the company’s stock worth $21,990,000 after purchasing an additional 246,322 shares during the last quarter. Finally, Jennison Associates LLC boosted its position in Acadia Healthcare by 26.1% in the fourth quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock worth $89,327,000 after purchasing an additional 238,114 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.